# Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

> **NCT00881361** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 756 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** systemic chemotherapy
- **PROCEDURE:** axillary lymph node dissection
- **PROCEDURE:** neoadjuvant therapy
- **PROCEDURE:** sentinel lymph node biopsy
- **PROCEDURE:** therapeutic conventional surgery
- **PROCEDURE:** ultrasound imaging

## Key facts

- **NCT ID:** NCT00881361
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-11
- **Final completion:** 2023-04-15
- **Target enrollment:** 756 (ACTUAL)
- **Last updated:** 2023-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00881361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00881361, "Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00881361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*